Cell Line Characteristics Predict Subsequent Resistance to Androgen Receptor-Targeted Agents (ARTA) in Preclinical Models of Prostate Cancer.

Moll, Jan Matthijs; Teubel, Wilma J; Erkens, Sigrun E; Jozefzoon-Agai, Ashraf; Dits, Natasja F; van Rijswijk, Angelique; Jenster, Guido W; van Weerden, Wytske M

Moll, Jan Matthijs; Teubel, Wilma J; Erkens, Sigrun E; Jozefzoon-Agai, Ashraf; Dits, Natasja F; van Rijswijk, Angelique; Jenster, Guido W; van Weerden, Wytske M.

Afiliação

Moll JM; Department of Urology, Erasmus Medical Centre (MC), Rotterdam, Netherlands.
Teubel WJ; Department of Urology, Erasmus Medical Centre (MC), Rotterdam, Netherlands.
Erkens SE; Department of Urology, Erasmus Medical Centre (MC), Rotterdam, Netherlands.
Jozefzoon-Agai A; Department of Urology, Erasmus Medical Centre (MC), Rotterdam, Netherlands.
Dits NF; Department of Urology, Erasmus Medical Centre (MC), Rotterdam, Netherlands.
van Rijswijk A; Department of Urology, Erasmus Medical Centre (MC), Rotterdam, Netherlands.
Jenster GW; Department of Urology, Erasmus Medical Centre (MC), Rotterdam, Netherlands.
van Weerden WM; Department of Urology, Erasmus Medical Centre (MC), Rotterdam, Netherlands.

Front Oncol ; 12: 877613, 2022.

Article em En | MEDLINE | ID: mdl-35769712

Palavras-chave

ARTA; CRPC; DuCaP; LAPC4; PC346C; VCaP

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google